web analytics

The Impact of a $480,000 Per Year Cancer Drug on Employer Health Coverage

Employers are expected to face another year of increased health costs, with the average health benefit cost per employee projected to rise by 8.2% in 2027, as reported by consulting firm Marsh. This marks the steepest increase since 2003.

Image of a bottle of the pancreatic cancer drug Rasonque, alongside its packaging.Revolution Medicines

Employers are bracing for another year of higher health costs, according to recent industry reports.

The average health benefit cost per employee is set to rise by 8.2% in 2027, even when taking into account measures businesses may take to contain costs, according to a survey released by consulting firm Marsh on Aug. 31. This represents the steepest hike since 2003.

Similar reports released by Aon and Business Group on Health estimate that employers will see

https://www.hr-brew.com/stories/rasonque-cancer-drug-employer-health-coverage?utm_source=&utm_medium=syndication&utm_campaign=feed

Read Complete Article

See also  Legislative lowdown: Federal agencies issue guidance on wellness programs

Get the Latest HR Headlines

* indicates required

HR NEWS MARKETPLACE


»Free CRM Audit from Dalia


»Cliquify + Top Employers Institute 2025 Employer Brand Priorities Report


»Access Applicants You Can’t Find Anywhere Else


»HR Technology Wire


»Job Board Directory


»Optimize Your Recruitment Marketing with Jobsync


»Recruiting Newsletters


»HR Tech News


»Jobs with Relocation Assistance


»Recruiter Ebooks